Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
NO donor; AR antagonist.
Dihydropyrazine found in Ligusticum walliichi. ...
5-HT1A partial agonist, SERT inhibitor.
Xanthine alkaloid found in coffee, tea, and oth...
Endogenous peptide hormone, GLP-1 fragment, inv...
STING antagonist
Synthetic peptide, vasopressin derivative; V2 a...
Bisphosphonate, chelating agent.
Synephrine is an endogenous alkaloid.
Triterpene aglycone found in Radix Astragali; t...
Active form of vitamin D, regulates dietary Ca2...
Macrolide; protein translation inhibitor, mamma...
Mas antagonist.
Histamine H2 antagonist, GSK-3β inhibitor.
1,8-Diaza-anthracene-tetrone; JNK and ERK5 inhi...
PDE3 inhibitor.
Hemantin inhibitor.
IGF-1R inhibitor.
Triazine, melamine derivative, insect growth re...
Dihydropyridine; L-type Ca2+ channel blocker.